Obesity and Diabetes
Research conducted at J. Vidal and co-authors has provided new information about obesity and diabetes
Published in Hospital Business Week, April 26th, 2009
According to recent research from Barcelona, Spain, "An enlarged incretin response after Roux-en-Y gastric bypass (RYGBP) has been proposed to promote excessive beta-cell function and mass. The objective of the study was to determine whether RYGBP is associated with a steadily increased glucagon-like peptide 1 (GLP-1) response and a disruption of the relationship between insulin sensitivity and insulin secretion required to maintain plasma glucose in the normal range."
"This was a cross-sectional study. Twenty-four women divided into three groups according to time after RYGBP (9-15, 21-30, and more than 36 months). Eight normal-weight and eight morbidly obese women...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- 1199SEIU United Healthcare Workers East
More than 800 Workers at Caritas St. Elizabeth's Medical Center Make History with Vote to join 1199SEIU - 3Com Corporation
Health-Care Organizations Worldwide Choose 3Com’s Advanced Networking and Security Solutions - A.M. Best Co.
A.M. Best Upgrades Ratings of Blue Whale Re Ltd. - ABS Systems
AristaCare Health Services to Install State-of-the-Art Quality Management and Business Intelligence Software from ABS Systems - AccelaRAD
SeeMyRadiology.com to Debut at HIMSS 2009 - Aetna
Aetna Signs Contract with Mississippi Health Partners - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
